Donald Trump has reportedly lost 30lbs since 2022, with fans praising his slimmer figure - but one doctor has warned he could ...

Research shows diabetes medications may cut Alzheimer's risk by up to 43% in patients with type 2 diabetes, offering ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Cardiovascular effectiveness was observed, largely independent of age, in a cohort of older patients with type 2 diabetes.

RFK also claimed, “We spent zero on chronic disease during the Kennedy administration. Today we spend $4.3 trillion a year.” ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced ...

If you're approaching 50 or have recently crossed that threshold, you might have noticed some changes. Here's what happens to ...

Studies expose how type 2 diabetes affects brain structure, potentially accelerating cognitive decline and offering new hope ...

States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There's also some evidence that if Medicaid patients lose weight with the drugs, they'll be ...

Expanding obesity treatment access could generate $10 trillion for the country by boosting productivity, cutting healthcare ...

President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...

Your body needs different vitamins and minerals as it ages. We talked to experts, and these are the best supplements for ...